Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata

References

• Abbasi F, Soltani S, Saghazadeh A, et al. (2017). PTPN22 single-nucleotide polymorphisms in iranian patients with Type 1 diabetes mellitus. Immunol Invest, 46, 409–418.
   PubMed Web of Science ®Google Scholar
• Ahmadloo S, Taghizadeh M, Akhiani M, et al. (2015). Single nucleotide polymorphism rs 2476601 of PTPN22 gene and susceptibility to rheumatoid arthritis in Iranian population. Iran J Allergy Asthma Immunol, 14, 437–442.
   PubMed Web of Science ®Google Scholar
• Akatsu T, Nakamura M, Satoh M, Hiramori K. (2003). Increased mRNA expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction. Clin Sci (Lond), 1979, 39–44.
   Google Scholar
• Aliagaoglu C, Pirim I, Atasoy M, et al. (2005). Association between alopecia areata and HLA Class I and II in Turkey. J Dermatol, 32, 711–714.
   PubMed Web of Science ®Google Scholar
• Alkhalifah A, Alsantali A, Wang E, et al. (2010). Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol, 62, 177–188. quiz 189-190.
   PubMed Web of Science ®Google Scholar
• Amirzargar A, Mytilineos J, Farjadian S, et al. (2001). Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum Immunol, 62, 1234–1238.
   PubMed Web of Science ®Google Scholar
• Babron M-C, Perdry H, Handel AE, et al. (2012). Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis. Eur J Hum Genet, 20, 321–325.
   PubMed Web of Science ®Google Scholar
• Betz RC, König K, Flaquer A, et al. (2008). The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata. Br J Dermatol, 158, 389–391.
   PubMed Web of Science ®Google Scholar
• Betz RC, Petukhova L, Ripke S, et al. (2015). Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun, 6, 5966.
   PubMed Web of Science ®Google Scholar
• Bhanusali DG, Sachdev A, Olson MA, et al. (2014). PTPN22 profile indicates a novel risk group in alopecia areata. Hum Immunol, 75, 81–87.
   PubMed Web of Science ®Google Scholar
• Biran R, Zlotogorski A, Ramot Y. (2015). The genetics of alopecia areata: new approaches, new findings, new treatments. J Dermatol Sci, 78, 11–20.
   PubMed Web of Science ®Google Scholar
• Bottini N, Musumeci L, Alonso A, et al. (2004). A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet, 36, 337–338.
   PubMed Web of Science ®Google Scholar
• Burn GL, Svensson L, Sanchez-Blanco C, et al. (2011). Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett, 585, 3689–3698.
   PubMed Web of Science ®Google Scholar
• Cheng G, Yu A, Malek TR. (2011). T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev, 241, 63–76.
   PubMed Web of Science ®Google Scholar
• Daroszewski J, Pawlak E, Karabon L, et al. (2009). Soluble CTLA-4 receptor an immunological marker of Graves’ disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms. Eur J Endocrinol, 161, 787–793.
   PubMed Web of Science ®Google Scholar
• El-Zawahry BM, Azzam OA, Zaki NS, et al. (2013). PTPN22 gene polymorphism in Egyptian alopecia areata patients and its impact on response to diphencyprone immunotherapy. Gene, 523, 147–151.
   PubMed Web of Science ®Google Scholar
• Entz P, Blaumeiser B, Betz RC, et al. (2006). Investigation of the HLA-DRB1 locus in alopecia areata. Eur J Dermatol, 16, 363–367.
   PubMed Web of Science ®Google Scholar
• Esmaili N, Mortazavi H, Chams-Davatchi C, et al. (2013). Association between HLA-DQB1*03:01 and Bullous pemphigoid in Iranian patients. Iran J Immunol, 10, 1–9.
   PubMed Web of Science ®Google Scholar
• Fichna M, Zurawek M, Fichna P, et al. (2012). Polymorphic variants of the IL2RA gene and susceptibility to type 1 diabetes in the Polish population. Tissue Antigens, 79, 198–203.
   PubMedGoogle Scholar
• Field J, Fox A, Jordan MA, et al. (2017). Interleukin-2 receptor-α proximal promoter hypomethylation is associated with multiple sclerosis. Genes Immun, 18, 59–66.
   PubMed Web of Science ®Google Scholar
• Gerold KD, Zheng P, Rainbow DB, et al. (2011). The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function. Diabetes, 60, 1955–1963.
   PubMed Web of Science ®Google Scholar
• Ghaderian SMH, Akbarzadeh Najar R, Tabatabaei Panah AS. (2011). Tumor necrosis factor-α: investigation of gene polymorphism and regulation of TACE-TNF-α system in patients with acute myocardial infarction. Mol Biol Rep, 38, 4971–4977.
   PubMed Web of Science ®Google Scholar
• Gough SCL, Simmonds MJ. (2007). The HLA region and autoimmune disease: associations and mechanisms of action. Curr Genomics, 8, 453–465.
   PubMed Web of Science ®Google Scholar
• Habib T, Funk A, Rieck M, et al. (2012). Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol, 1950, 487–496.
   Google Scholar
• Hashemi M, Atabaki M, Daneshvar H, et al. (2013). Association of PTPN22 rs2476601 and EGFR rs17337023 gene polymorphisms and rheumatoid arthritis in Zahedan, Southeast Iran. Int J Immunogenet, 40, 299–305.
   PubMed Web of Science ®Google Scholar
• John KK-G, Brockschmidt FF, Redler S, et al. (2011). Genetic variants in CTLA4 are strongly associated with alopecia areata. J Invest Dermatol, 131, 1169–1172.
   PubMed Web of Science ®Google Scholar
• Kawasaki E, Awata T, Ikegami H, et al. (2009). Genetic association between the interleukin-2 receptor-alpha gene and mode of onset of type 1 diabetes in the Japanese population. J Clin Endocrinol Metab, 94, 947–952.
   PubMed Web of Science ®Google Scholar
• Kemp EH, McDonagh AJG, Wengraf DA, et al. (2006). The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata. Hum Immunol, 67, 535–539.
   PubMed Web of Science ®Google Scholar
• Klocke K, Sakaguchi S, Holmdahl R, Wing K. (2016). Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood. Proc Natl Acad Sci U S A, 113, E2383–2392.
   PubMed Web of Science ®Google Scholar
• Marques Da Costa C, Dupont E, Van der Cruys M, et al. (2006). Earlier occurrence of severe alopecia areata in HLA-DRB1*11-positive patients. Dermatol, 213, 12–14.
   PubMed Web of Science ®Google Scholar
• Martinez-Mir A, Zlotogorski A, Gordon D, et al. (2007). Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet, 80, 316–328.
   PubMed Web of Science ®Google Scholar
• Megiorni F, Mora B, Maxia C, et al. (2013). Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in alopecia areata: a case-control association study in the Italian population. Arch Dermatol Res, 305, 665–670.
   PubMed Web of Science ®Google Scholar
• Miao Y, Kang Z, Xu F, et al. (2013). Association analysis of the IL2RA gene with alopecia areata in a Chinese population. Dermatol, 227, 299–304.
   PubMed Web of Science ®Google Scholar
• Mowla K, Rajai E, Sabbaghan A, et al. (2015). Investigating the association of PTPN22 gene polymorphism R620W with scleroderma in Southwestern Iran in Khuzestan. Biomed Pharmacol J, 8, 1135–1140.
   Google Scholar
• Olsen EA, Hordinsky MK, Price VH, et al. (2004). Alopecia areata investigational assessment guidelines–part II. National Alopecia Areata Foundation. J Am Acad Dermatol, 51, 440–447.
   PubMed Web of Science ®Google Scholar
• Patel H, Mansuri MS, Singh M, et al. (2016). Association of cytotoxic T-lymphocyte antigen 4 (CTLA4) and thyroglobulin (TG) genetic variants with autoimmune hypothyroidism. PloS One, 11, e0149441.
   PubMed Web of Science ®Google Scholar
• Paterson AM, Lovitch SB, Sage PT, et al. (2015). Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity. J Exp Med, 212, 1603–1621.
   PubMed Web of Science ®Google Scholar
• Petukhova L, Christiano AM. (2016). Functional interpretation of genome-wide association study evidence in alopecia areata. J Invest Dermatol, 136, 314–317.
   PubMed Web of Science ®Google Scholar
• Petukhova L, Duvic M, Hordinsky M, et al. (2010). Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature, 466, 113–117.
   PubMed Web of Science ®Google Scholar
• Rabbani A, Abbasi F, Taghvaei M, et al. (2013). HLA-DRB, -DQA, and DQB alleles and haplotypes in Iranian patients with diabetes mellitus Type I. Pediatr Diabetes, 14, 366–371.
   PubMed Web of Science ®Google Scholar
• Redler S, Albert F, Brockschmidt FF, et al. (2012). Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areata. Br J Dermatol, 167, 1360–1365.
   PubMed Web of Science ®Google Scholar
• Ronninger M, Guo Y, Shchetynsky K, et al. (2012). The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls. Genome Med, 4, 2.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, Ono M. (2008). Regulatory T cells and immune tolerance. Cell, 133, 775–787.
   PubMed Web of Science ®Google Scholar
• Salinas-Santander M, Sánchez-Domínguez C, Cantú-Salinas C, et al. (2015). Association between PTPN22 C1858T polymorphism and alopecia areata risk. Exp Ther Med, 10, 1953–1958.
   PubMed Web of Science ®Google Scholar
• Scalapino KJ, Daikh DI. (2008). CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev, 223, 143–155.
   PubMed Web of Science ®Google Scholar
• Shams S, Amirzargar AA, Yousefi M, et al. (2009). HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris. J Clin Immunol, 29, 175–179.
   PubMed Web of Science ®Google Scholar
• Ueda H, Howson JMM, Esposito L, et al. (2003). Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 423, 506–511.
   PubMed Web of Science ®Google Scholar
• Villasante Fricke AC, Miteva M. (2015). Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol, 8, 397–403.
   PubMed Web of Science ®Google Scholar
• Williams F, Meenagh A, Single R, et al. (2004). High resolution HLA-DRB1 identification of a Caucasian population. Hum Immunol, 65, 66–77.
   PubMed Web of Science ®Google Scholar